LONDON BRIEFING: AstraZeneca plans listing changes; GSK names next CEO
(Alliance News) - AstraZeneca plans changes to its US listing and to retain its position in London, GSK promotes its chief commercial officer to lead the company while Merchants Trust raises its dividend. Read More